Ocuphire Pharma Inc OCUP:NASDAQ

RT Quote | NASDAQ | USD
Last | 09/20/21 EDT
5.12quote price arrow down-0.07 (-1.35%)
Volume
540,853
52 week range
3.68 - 13.81
Loading...
  • Open5.01
  • Day High5.23
  • Day Low4.85
  • Prev Close5.12
  • 52 Week High13.81
  • 52 Week High Date02/03/21
  • 52 Week Low3.68
  • 52 Week Low Date11/09/20

Key Stats

  • Market Cap86.53M
  • Shares Out16.90M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta0.37
  • YTD % Change-21.11

KEY STATS

  • Open5.01
  • Day High5.23
  • Day Low4.85
  • Prev Close5.12
  • 52 Week High13.81
  • 52 Week High Date02/03/21
  • 52 Week Low3.68
  • 52 Week Low Date11/09/20
  • Market Cap86.53M
  • Shares Out16.90M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta0.37
  • YTD % Change-21.11

RATIOS/PROFITABILITY

  • EPS (TTM)-6.29
  • P/E (TTM)-0.81
  • Fwd P/E (NTM)-3.68
  • EBITDA (MRQ)-18.886M
  • ROE (MRQ)-457.92%
  • Revenue (MRQ)-1.05M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-553.94%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date10/27/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ocuphire Pharma Inc

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Ocuphire Pharma, Inc., formerly Rexahn Pharmaceuticals, Inc., is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of eye disorders. Its pipeline includes two small-molecule product candidates targeting front and back of the eye indications. Its lead product candidate, Nyxol Eye Drops, is a once-daily preservative-free eye drop formulation of phentolamine mesylate designed to reduce pupil...
Cam Gallagher
Chairman
Mina Sooch
President
Amy Rabourn
Chief Accounting Officer
Address
37000 Grand River Ave., Suite 120
Farmington Hills, MI
48335
United States

Top Peers

SYMBOLLASTCHG%CHG
ONCS
OncoSec Medical Inc
2.06-0.13-5.94%
LUMO
Lumos Pharma Inc
9.98-0.03-0.30%
FWP
Forward Pharma A/S
6.02-0.07-1.15%
AADI
Aadi Bioscience Inc
29.09-0.26-0.89%
TARA
Protara Therapeutics Inc
7.00-0.24-3.31%